Bicycle Therapeutics Receives Additional Seed Funding
Bicycle Therapeutics Ltd, a Babraham Research Campus, Cambridge, UK-based biotechnology company developing a novel technology platform for the identification and optimisation of chemically constrained cyclic peptides with high target specificity and binding affinity, received additional seed funding. New investors include SR One, the independent corporate venture fund of GlaxoSmithKline, and SV Life Sciences. In conjunction […]